RILZABRUTINIB

564 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking RILZABRUTINIB:

# Side effect Count
0 PLATELET COUNT DECREASED 143
1 DIARRHOEA 142
2 NAUSEA 105
3 DRUG INEFFECTIVE 92
4 HEADACHE 52
5 FATIGUE 50
6 PRODUCT USE IN UNAPPROVED INDICATION 47
7 ABDOMINAL DISCOMFORT 39
8 VOMITING 29
9 DIZZINESS 23
See all common reactions for RILZABRUTINIB

RILZABRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYCOPLASMA GENITALIUM INFECTION 1 0.0526
1 EAR DRYNESS 1 0.0095
2 EPENDYMOMA 1 0.0069
3 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
4 SCHWANNOMA 1 0.0050
5 VIRAL SINUSITIS 1 0.0047
6 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
7 GALLBLADDER ENLARGEMENT 4 0.0037
8 VOCAL CORD INFLAMMATION 1 0.0034
9 PLATELET COUNT ABNORMAL 20 0.0033
See all enriched reactions for RILZABRUTINIB